SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

7924 (7924) News

Follow 7924 (7924) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 7924 Asset market Sector Markets 90 days 1 Updated Oct 19, 2026, 10:07 AM UTC Open live news feed
M TLC BioSciences Reports Positive TLC590 Phase 3 Topline Results TLC BioSciences says its pivotal Phase 3 trial of investigational TLC590 showed statistically significant reductions in pain and opioid use versus placebo and liposomal bupivacaine. EQUITY | Oct 19, 2026, 10:07 AM UTC